Think Like a Scientist

In this show, we break down barriers between scientific-thinking and modern-day actions by interviewing groundbreaking leaders to provide you real-life tools and experiences that you can use to bring positive impact. 

Do your New Year's Resolution more often start with, "I should do more of..." than "I should do less of..."? Do you spend more time acquiring information than you spend distilling what you already know? In this episode I talk about subtraction, the power of doing less, and how to do less. 

You would think that I just learned how to be confident in what I know, but it was more about how I silenced my ego. What I don't know will always be greater than what I do know. So, why not just be comfortable with being wrong?

Science isn’t just a bunch of people fiddling around with test tubes and microscopes. It’s a way of thinking about the world: a mental toolbox for solving problems. As we think and talk, we often slip into the mindset of three different professions: preachers, prosecutors, and politicians. But being a scientist is not just a profession, it’s a frame of mind that differs from preaching, prosecuting, and politicking. Understanding how to implement this principle will empower you on how to build effective systems, better habits, and all that fancy stuff. 

Stanford Research Paper: 

Implicit Theories of Interest: Finding Your Passion or Developing It?

Entrepreneurs Who Think Like Scientists Get Better Results:

A Scientific Approach to Entrepreneurial Decision Making: Evidence from a Randomized Control Trial

Lessons and insights I learned the last year. 

Lessons and insights learned from the last year. 

What will be the future of cancer therapy? In this episode I discuss the major key takeaways from the recently published paper and established project: "The Human Proteoform Project: Defining the human proteome." 

Ranging from stories of a six year old girl, among many, who was cured from childhood cancer using immunotherapy. We've known that strategies like chemotherapy and immune-supression like insulin have only been partially successful. What have we been missing this whole time? I discuss how the emerging field of precision medicine takes into account the other half of what has been missed—which will increase the efficacy and aid the development of novel therapeutics that are both preventative and curative. 

The Human Proteoform Project: Defining the human proteome: 

https://doi.org/10.1126/sciadv.abk0734

Differences between germline genomes of monozygotic twins:

https://www.nature.com/articles/s41588-020-00755-1